Overview

Raloxifene for Women With Alzheimer's Disease

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This is a multisite pilot randomized trial of raloxifene or placebo for the treatment of women with Alzheimer's disease.
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Collaborators:
Indiana University
Kaiser Permanente
Southern Illinois University
Treatments:
Raloxifene Hydrochloride